Anna Berkenblit, Chief Scientific and Medical Officer of Pancreatic Cancer Action Network, shared a post on LinkedIn:
“It was a pleasure to visit the National Cancer Institute (NCI) today alongside PanCAN President and CEO Julie Fleshman for a thoughtful conversation with NCI Director Dr. Anthony Letai about the current state of research for pancreatic cancer, what’s needed to keep up the momentum during this exciting time and the critical work ahead to improve outcomes for patients and families.
It was great to reconnect with Tony after training together years ago at Brigham and Women’s Hospital, and meaningful to see leaders across research, medicine and advocacy continuing to come together with a shared commitment to advancing progress against this disease!”
Other articles about Pancreatic Cancer on OncoDaily.